Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.
- DOI
- 10.2147/cmar.s621884
- Published
- 2026
- Container
- Cancer management and research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/cmar.s621884,
title = {Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.},
author = {Chen Q and Lin X and Chen L and Yao J and Yan Y and Zhang X and Yang D and Lin X and Chen S and Chen X and Yu N},
year = {2026},
journal = {Cancer management and research},
doi = {10.2147/cmar.s621884},
url = {https://doi.org/10.2147/cmar.s621884}
}RIS
TY - JOUR TI - Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports. AU - Chen Q AU - Lin X AU - Chen L AU - Yao J AU - Yan Y AU - Zhang X AU - Yang D AU - Lin X AU - Chen S AU - Chen X AU - Yu N PY - 2026 JO - Cancer management and research DO - 10.2147/cmar.s621884 UR - https://doi.org/10.2147/cmar.s621884 ER -
APA
Q, C., X, L., L, C., J, Y., Y, Y., X, Z., D, Y., X, L., S, C., X, C., & N, Y. (2026). Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.. Cancer management and research. https://doi.org/10.2147/cmar.s621884
Source records
- pubmed · retrieved 2026-09-26T03:40:28.694Z